DK0614362T5 - Farmaceutiske præparater på basis af ebastin eller dermed analoge forbindelser - Google Patents

Farmaceutiske præparater på basis af ebastin eller dermed analoge forbindelser

Info

Publication number
DK0614362T5
DK0614362T5 DK93901804T DK93901804T DK0614362T5 DK 0614362 T5 DK0614362 T5 DK 0614362T5 DK 93901804 T DK93901804 T DK 93901804T DK 93901804 T DK93901804 T DK 93901804T DK 0614362 T5 DK0614362 T5 DK 0614362T5
Authority
DK
Denmark
Prior art keywords
pct
ebastine
pharmaceutical preparations
analogous compounds
preparations based
Prior art date
Application number
DK93901804T
Other languages
English (en)
Other versions
DK0614362T3 (da
Inventor
Michel Veillard
Jean-Marc Bobee
Guillaume Conrath
Gabriel Gousset
Michel Ponsot
Original Assignee
Almirall Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=9419600&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK0614362(T5) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Almirall Lab filed Critical Almirall Lab
Publication of DK0614362T3 publication Critical patent/DK0614362T3/da
Application granted granted Critical
Publication of DK0614362T5 publication Critical patent/DK0614362T5/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Hydrogenated Pyridines (AREA)
DK93901804T 1991-12-03 1992-12-01 Farmaceutiske præparater på basis af ebastin eller dermed analoge forbindelser DK0614362T5 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9114936A FR2684298B1 (fr) 1991-12-03 1991-12-03 Nouvelles compositions pharmaceutiques solides a base de derives de lapiperidine substitues en 1,4.
PCT/FR1992/001116 WO1993010782A1 (fr) 1991-12-03 1992-12-01 Compositions pharmaceutiques a base d'ebastime ou de ses analoques

Publications (2)

Publication Number Publication Date
DK0614362T3 DK0614362T3 (da) 1997-03-10
DK0614362T5 true DK0614362T5 (da) 2008-11-10

Family

ID=9419600

Family Applications (1)

Application Number Title Priority Date Filing Date
DK93901804T DK0614362T5 (da) 1991-12-03 1992-12-01 Farmaceutiske præparater på basis af ebastin eller dermed analoge forbindelser

Country Status (12)

Country Link
US (1) US5460829A (da)
EP (1) EP0614362B1 (da)
JP (1) JP3518601B2 (da)
AT (1) ATE148990T1 (da)
CA (1) CA2123232C (da)
DE (1) DE69217554T2 (da)
DK (1) DK0614362T5 (da)
ES (1) ES2097490T3 (da)
FR (1) FR2684298B1 (da)
GR (1) GR3022615T3 (da)
HK (1) HK1006273A1 (da)
WO (1) WO1993010782A1 (da)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5717025A (en) * 1996-09-16 1998-02-10 H. B. Fuller Licensing & Financing, Inc. Melamine-formaldehyde resin based adhesive compositions
JP2007246539A (ja) * 1997-10-20 2007-09-27 Dainippon Sumitomo Pharma Co Ltd 速溶性医薬組成物
US6737550B2 (en) 2001-06-13 2004-05-18 Biogal Gryogyszergyar Rt. Process for preparing rac-bicalutamide and its intermediates
AU2003221355A1 (en) * 2002-03-12 2003-09-22 Y's Therapeutics Co., Limited Compounds capable of inhibiting immunocyte-related allergic immune reactions
JPWO2003103713A1 (ja) * 2002-06-10 2005-10-06 大日本製薬株式会社 速崩壊性錠剤及びその製造方法
US20050008691A1 (en) * 2003-05-14 2005-01-13 Arturo Siles Ortega Bicalutamide compositions
ES2231043B2 (es) * 2004-10-29 2005-10-01 Laboratorios Cinfa, S.A. Composicion farmaceutica de ebastina de liberacion inmediata y su proceso de fabricacion.
EP1716848B1 (en) * 2005-04-25 2007-04-25 Laboratorios Alter, S.A. Solid pharmaceutical composition containing a crystalline derivative of piperidine substituted in the 1,4 position
CA2611475A1 (en) * 2005-06-09 2006-12-21 Elan Pharma International, Limited Nanoparticulate ebastine formulations
ES2277767B1 (es) * 2005-11-04 2008-04-01 Simbec Iberica, S.L. Formas orales solidas de ebastina.
JP2007297348A (ja) * 2006-05-02 2007-11-15 Daito Kk エバスチンを含有する錠剤
US8617597B2 (en) 2006-07-06 2013-12-31 Bayer Intellectual Property Gmbh Pharmaceutical composition containing a tetrahydrofolic acid
DE102008000351B4 (de) 2008-02-20 2017-08-10 Aristo Pharma Gmbh Verfahren zur Herstellung eines Ebastin enthaltenden Granulats sowie einer festen pharmazeutischen Zusammensetzung, Ebastin enthaltendes Granulat und dessen Verwendung
DE202011000756U1 (de) 2011-03-31 2011-10-12 Micro Labs Limited Ebastine, nicht-mikronisierte Ebastinepartikel und pharmazeutische Zusammensetzungen umfassend Ebastine
WO2013062498A1 (en) * 2011-10-13 2013-05-02 Mahmut Bilgic Solid oral formulations comprising ebastine
WO2013081562A1 (en) 2011-10-13 2013-06-06 Mahmut Bilgic Oral formulations comprising ebastine
ES2606148T3 (es) 2011-11-01 2017-03-22 Inopharm Limited Composición de disgregación oral de agentes antihistamínicos
US10058542B1 (en) 2014-09-12 2018-08-28 Thioredoxin Systems Ab Composition comprising selenazol or thiazolone derivatives and silver and method of treatment therewith
CN105326802A (zh) * 2015-09-01 2016-02-17 杭州澳医保灵药业有限公司 一种依巴斯汀分散片及其制备方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8321157D0 (en) * 1983-08-05 1983-09-07 Fordonal Sa Piperidine derivatives
US4871733A (en) * 1984-04-09 1989-10-03 Analgesic Associates Cough/cold mixtures comprising non-sedating antihistamine drugs
US4783465A (en) * 1984-04-09 1988-11-08 Analgesic Associates Cough/cold mixtures comprising non-sedating antihistamine drugs
US4975426A (en) * 1987-06-08 1990-12-04 Analgesic Associates Cough/cold mixtures comprising non-sedating antihistamine drugs
US4829064A (en) * 1987-06-08 1989-05-09 Analgesic Associates Cough/cold mixtures comprising non-sedating antihistamine drugs
DE3720493A1 (de) * 1987-06-20 1989-01-26 Nattermann A & Cie Arzneizubereitungen mit mikronisierten ebselen-kristallen
WO1989010143A1 (en) * 1988-04-27 1989-11-02 Schering Corporation Certain paf antagonist antihistamine combinations and methods
JP2642486B2 (ja) * 1989-08-04 1997-08-20 田辺製薬株式会社 難溶性薬物の超微粒子化法
US5356887A (en) * 1990-01-31 1994-10-18 Merck & Co., Inc. Pharmaceutical compositions containing insoluble calcium salts of amino-hydroxybutylidene bisphoshonic acids
US5271944A (en) * 1991-04-05 1993-12-21 Biofor, Ltd. Pharmacologically enhanced formulations

Also Published As

Publication number Publication date
ES2097490T3 (es) 1997-04-01
CA2123232C (fr) 2005-02-15
CA2123232A1 (fr) 1993-06-10
GR3022615T3 (en) 1997-05-31
FR2684298A1 (fr) 1993-06-04
FR2684298B1 (fr) 1994-03-11
DK0614362T3 (da) 1997-03-10
JP3518601B2 (ja) 2004-04-12
US5460829A (en) 1995-10-24
ATE148990T1 (de) 1997-03-15
DE69217554T2 (de) 1997-08-07
HK1006273A1 (en) 1999-02-19
DE69217554D1 (de) 1997-03-27
WO1993010782A1 (fr) 1993-06-10
JPH07501533A (ja) 1995-02-16
EP0614362B1 (fr) 1997-02-19
EP0614362A1 (fr) 1994-09-14

Similar Documents

Publication Publication Date Title
DK0614362T5 (da) Farmaceutiske præparater på basis af ebastin eller dermed analoge forbindelser
FI962324A (fi) N-substituoituja atsabisykloalkaanijohdannaisia neuroleptisinä aineina ASF
MY117274A (en) Polycyclic amine compounds and their enantiomers,their method of preparation and pharmaceutical compositions in which they are present.
IL110494A0 (en) Perhydroisoindole derivatives, their preparation and pharmaceutical compositions which contain them
DK0414263T3 (da) Fremgangsmåde til stabilisering af et fast farmaceutisk præparat indeholdende cycliske aminosyrer
NZ225344A (en) 3-demethylmevalonic acid derivatives and lactones and pharmaceutical compositions; intermediates for the preparation thereof
PL314188A1 (en) Novel derivatives of benzoguanidine, method of obtaining them and their application in pharmaceutical compositions
BG100946A (en) New amino acid derivatives, method for their preparation and pharmaceutical compositions containing them
NL980012I1 (nl) Mometasonfuroaat-monohydraat, werkwijze om zulks te bereiden en farmaceutische samenstellingen.
DK0623121T3 (da) Fremstilling af N-acetylneuraminsyrederivater
FI913556A (fi) Nya piperidyletrar och -tioetrar som inhibitorer av kolesterolbiosyntes.
DK0450420T3 (da) Heterocyclisk substituerede dihydropyridiner, fremgangsmåde til deres fremstilling og deres anvendelse i lægemidler
NO962285L (no) N-substituerte azabicykloheptan-derivater anvendt for eksempel som neuroleptika
DK0623138T3 (da) Nye adenosinderivater, fremgangsmåder til deres fremstilling og farmaceutiske præparater med indhold deraf
KR900003177A (ko) 테트라시클릭계 우울증 치료제
DK0625153T3 (da) Nyt isoindolinonderivat, dets fremstilling og farmaceutiske præparater med et indhold deraf
EP1132383A4 (en) NEW AGAROFURAN DERIVATIVES, THEIR PRODUCTION, PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM AND THEIR USE AS MEDICINE
MY159418A (en) New derivatives of flavones, their preparation process, their use as medicaments, pharmaceutical compositions and new use
IT1274483B (it) Composizioni farmaceutiche contenenti gemfibrozil
DE69900466D1 (de) Orale zusammensetzungen mit niedrigdosierten zytotoxischen proteinen
DK0876393T3 (da) 21-(2-oxo-tetrahydrofuran)-thio-pregnanderivater, fremgangsmåde til fremstilling deraf og farmaceutiske præparater indehold